Asia-Pacific journal of clinical oncology
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Real-World Results From an Early Access Program in Malaysia.
Fuad Bin Ismail, Mohamed Ibrahim Abdul Wahid, Muthukkumaran Thiagarajan, Ai Lian Tan, Nellie Lay Chin Cheah, Kai Seng Lam, Doris Sze Ying Chow, Soo Fan Ang, Michelle Ng, Hannah Loke, John Seng Hooi Low
Published: 202510.1111/ajco.70042
Abstract
AIM: Avelumab first-line (1L) maintenance was approved for treatment of advanced urothelial carcinoma (UC) based on results from the JAVELIN Bladder 100 Phase 3 trial. We report real-world data from an early access program (EAP) for avelumab 1L maint…
Preview only. Read the full abstract at the source